Studies on PD-1/PD-L1 mAbs in CML, ALL, and CLL are few, and more details about clinical trials on PD-1/PD-L1 mAbs in the treatment of leukemia are shown in Table 3. The gene discussed is PDCD1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.